Drug intelligence / Profile preview

iodine-125 seed

Development stage
Unknown
Lead developer
Eckert & Ziegler
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Interstitial, Implant, Ophthalmic
01

Overview

Iodine-125 seeds are small sealed sources of the radioactive isotope iodine-125 used primarily in brachytherapy for the treatment of localized cancers. The seeds are typically encapsulated in titanium and permanently implanted into or near tumor tissue using needles. Once implanted, they emit low-dose-rate gamma and X-ray radiation continuously over weeks to months. This radiation causes DNA damage in tumor cells through direct ionization and generation of reactive oxygen species, leading to cell cycle arrest (G2/M), inhibition of mitosis, apoptosis induction, reduced proliferation and metastasis potential. The main clinical indication is permanent interstitial treatment for localized prostate cancer; other uses include eye plaque therapy for ocular tumors and localization/therapy for breast lesions or other solid tumors. Multiple manufacturers produce these seeds under various brand names with strict quality controls on radioactivity calibration and biocompatibility[1][2][3][4][5][6][7][8].

Brand names
IsoSeedAdvantage I-125BrachySource I-125 SeedBest Iodine-125 Seed
Other names
iodine-125 brachytherapy seediodine125 brachytherapy seediodine 125 brachytherapy seedradioactive iodine seed
02

Targets

MicrotubuleDNA

Beyond the preview

Go deeper on iodine-125 seed.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on iodine-125 seed.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call